Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed

IL-23 Plasma level measurement in relapsing remitting multiple sclerosis (RRMS) patients compared to healthy subjects.
An expanded composite scale of MRI-defined disease severity in multiple sclerosis: MRDSS2.
Percutaneous transluminal angioplasty for treatment of chronic cerebrospinal venous insufficiency (CCSVI) in multiple sclerosis patients.
Prevalence and natural history of pain in adults with multiple sclerosis: Systematic review and meta-analysis.
[Good practice in prophylactic care: prophylactic care and professional activation of employees with multiple sclerosis].
Vaccine against autoimmune disease: can helminths or their products provide a therapy?
Relapse of multiple sclerosis in a patient retaining CCR7-expressing T cells in CSF under fingolimod therapy.
Treatment failure of intrathecal baclofen and supra-additive effect of nabiximols in multiple sclerosis-related spasticity: a case report.
Assessment of urinary incontinence in the women in Eastern Turkey.
[Treatment of neuromyelitis optica].
IFNγ Influences Type I Interferon Response and Susceptibility to Theiler's Virus-Induced Demyelinating Disease.
Determinants of sexual dysfunction in women with multiple sclerosis.
Comorbidities at multiple sclerosis diagnosis.
Synergistic effects of atorvastatin and all-trans retinoic acid in ameliorating animal model of multiple sclerosis.
Functional brain network analysis using minimum spanning trees in Multiple Sclerosis: An MEG source-space study.
Effects of Multiple Sclerosis on Female Sexuality: A Controlled Study.
Multiple sclerosis in 2013: Novel triggers, treatment targets and brain atrophy measures.
Fingolimod does not enhance cerebellar remyelination in the cuprizone model.
Distal acquired demyelinating symmetric neuropathy associated with colorectal adenocarcinoma: Should it be termed paraneoplastic?
Costs of Illness of Multiple Sclerosis In Sweden - A Population-Based Register Study.
Smoking Beyond Multiple Sclerosis Diagnosis: A Risk Factor Still Worth Modifying.
Myeloid cell-based therapies in neurological disorders: How far have we come?
Insights into the channel gating of P2X receptors from structures, dynamics and small molecules.
Current management of relapsing-remitting multiple sclerosis.
The profile of patients followed at the Neuroimmunology Clinic at UNIFESP: 20 years analysis.

Pages